BHC Price / Book | Bausch Health Companies Inc.

Bausch Health Companies Inc. (BHC) Price / Book

2020-12-31: Price/Book Ratio 13.82.
2020-09-30: Price/Book Ratio 9.4.
2020-06-30: Price/Book Ratio 13.7.
2020-03-31: Price/Book Ratio 7.64.

Historical market capitalization divided by filed shareholder equity.

Available history: 2009-12-31 to 2020-12-31
Data captured: 2026-09-04

Historical Price/Book Ratio

Date	Price/Book Ratio
2020-12-31	13.82
2020-09-30	9.4
2020-06-30	13.7
2020-03-31	7.64
2019-12-31	9.92
2019-09-30	3.1
2019-06-30	3.42
2019-03-31	3.23
2018-12-31	2.36
2018-09-30	2.85
2018-06-30	2.34
2018-03-31	1.23
2017-12-31	1.24
2017-09-30	0.94
2017-06-30	1.53
2017-03-31	0.99
2016-12-31	1.6
2016-09-30	2.05
2016-06-30	1.3
2016-03-31	1.6
2015-12-31	5.9
2015-09-30	9.65
2015-06-30	11.83
2015-03-31	10.54
2014-12-31	9.06
2014-09-30	8.55
2014-06-30	8.01
2014-03-31	8.64
2013-12-31	7.64
2013-09-30	7.01
2013-06-30	5.02
2013-03-31	6.35
2012-12-31	4.89
2012-09-30	4.42
2012-06-30	3.66
2012-03-31	4.02
2011-12-31	3.64
2011-09-30	2.84
2011-06-30	3.34
2011-03-31	3.15
2010-12-31	1.74
2010-09-30	1.38
2010-06-30	2.24
2009-12-31	1.63

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Braveheart Bio, Inc. (BRVE)	United States	$2.106B
PALVELLA THERAPEUTICS, INC. (PVLA)	United States	$2.105B	-35.55
Trevi Therapeutics, Inc. (TRVI)	United States	$2.091B	-51.93
OCULAR THERAPEUTIX, INC (OCUL)	United States	$2.159B	-7.15
Prestige Consumer Healthcare Inc. (PBH)	United States	$2.163B	13.03
Generate Biomedicines, Inc. (GENB)	United States	$2.052B
PERRIGO Co plc (PRGO)	Ireland	$2.038B	-0.79
NEKTAR THERAPEUTICS (NKTR)	United States	$2.026B	-9.05
Aurinia Pharmaceuticals Inc. (AUPH)		$2.207B	7.18
UroGen Pharma Ltd. (URGN)		$2.015B	-18.42